- Home
- TECX vs SRDX Comparison
TECX vs SRDX Comparison
Compare TECX & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- SRDX
- Stock Information
- Founded
- TECX 2019
- SRDX 1979
- Country
- TECX United States
- SRDX United States
- Employees
- TECX N/A
- SRDX N/A
- Industry
- TECX
- SRDX Medical/Dental Instruments
- Sector
- TECX
- SRDX Health Care
- Exchange
- TECX Nasdaq
- SRDX Nasdaq
- Market Cap
- TECX 647.7M
- SRDX 562.6M
- IPO Year
- TECX 2018
- SRDX 1998
- Fundamental
- Price
- TECX $47.44
- SRDX $39.75
- Analyst Decision
- TECX Strong Buy
- SRDX Hold
- Analyst Count
- TECX 5
- SRDX 4
- Target Price
- TECX $72.25
- SRDX $43.00
- AVG Volume (30 Days)
- TECX 93.8K
- SRDX 177.1K
- Earning Date
- TECX 11-07-2024
- SRDX 01-30-2025
- Dividend Yield
- TECX N/A
- SRDX N/A
- EPS Growth
- TECX N/A
- SRDX N/A
- EPS
- TECX N/A
- SRDX N/A
- Revenue
- TECX N/A
- SRDX $126,078,000.00
- Revenue This Year
- TECX N/A
- SRDX $13.75
- Revenue Next Year
- TECX N/A
- SRDX $13.67
- P/E Ratio
- TECX N/A
- SRDX N/A
- Revenue Growth
- TECX N/A
- SRDX N/A
- 52 Week Low
- TECX $1.40
- SRDX $25.17
- 52 Week High
- TECX $53.34
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- TECX 53.77
- SRDX 55.78
- Support Level
- TECX $42.83
- SRDX $39.50
- Resistance Level
- TECX $48.85
- SRDX $40.39
- Average True Range (ATR)
- TECX 3.42
- SRDX 0.38
- MACD
- TECX -0.84
- SRDX -0.06
- Stochastic Oscillator
- TECX 43.97
- SRDX 46.67
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.